Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York
IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion ...
MRI scan could fast-track patients for bladder cancer treatment, study finds
An MRI instead of a surgical procedure helped speed up the wait between diagnosis and treatment, UK research has found ...
Cure Today17h
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery ...
Zacks.com on MSN12h
Can Gilead Sciences Sustain Its Growth Momentum in 2025?
Biotech giant Gilead Sciences, Inc. GILD has put up a strong performance amid a volatile market. Shares of this biotech giant ...
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Sees Large Growth in Short Interest
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 5,500,000 shares, a growth of 8.7 ...